Middle East Respiratory Syndrome Coronavirus Gene 5 Modulates Pathogenesis in Mice
Javier Gutierrez-Alvarez1, Li Wang1, Raul Fernandez-Delgado1
1Department of Molecular and Cell Biology, National Center of Biotechnology (CNB-CSIC), Campus Universidad Autónoma de Madrid, Madrid, Spain.
Abstract:
Middle East respiratory syndrome coronavirus (MERS-CoV) causes a highly lethal pneumonia that emerged in 2012. There is limited information on MERS-CoV pathogenesis, as data from patients are scarce and the generation of animal models reproducing MERS clinical manifestations has been challenging. Human dipeptidyl peptidase 4 knock-in (hDPP4-KI) mice and a mouse-adapted MERS-CoV strain (MERSMA-6-1-2) were recently described. hDPP4-KI mice infected with MERSMA-6-1-2 show pathological signs of respiratory disease, high viral titers in the lung, and death. In this work, a mouse-adapted MERS-CoV infectious cDNA was engineered by introducing nonsynonymous mutations contained in the MERSMA-6-1-2 genome into a MERS-CoV infectious cDNA, leading to a recombinant mouse-adapted virus (rMERS-MA) that was virulent in hDDP4-KI mice. MERS-CoV adaptation to cell culture or mouse lungs led to mutations and deletions in genus-specific gene 5 that prevented full-length protein expression. In contrast, analysis of 476 MERS-CoV field isolates showed that gene 5 is highly stable in vivo in both humans and camels. To study the role of protein 5, two additional viruses were engineered expressing a full-length gene 5 (rMERS-MA-5FL) or containing a complete gene 5 deletion (rMERS-MA-Δ5). rMERS-MA-5FL virus was unstable, as deletions appeared during passage in different tissue culture cells, highlighting MERS-CoV instability. The virulence of rMERS-MA-Δ5 was analyzed in a sublethal hDPP4-KI mouse model. Unexpectedly, all mice died after infection with rMERS-MA-Δ5, in contrast to those infected with the parental virus, which contains a 17-nucleotide (nt) deletion and a stop codon in protein 5 at position 108. Expression of interferon and proinflammatory cytokines was delayed and dysregulated in the lungs of rMERS-MA-Δ5-infected mice. Overall, these data indicated that the rMERS-MA-Δ5 virus was more virulent than the parental one and suggest that the residual gene 5 sequence present in the mouse-adapted parental virus had a function in ameliorating severe MERS-CoV pathogenesis.IMPORTANCE Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic virus causing human infections with high mortality rate (∼35%). Animal models together with reverse-genetics systems are essential to understand MERS-CoV pathogenesis. We developed a reverse-genetics system for a mouse-adapted MERS-CoV that reproduces the virus behavior observed in humans. This system is highly useful to investigate the role of specific viral genes in pathogenesis. In addition, we described a virus lacking gene 5 expression that is more virulent than the parental one. The data provide novel functions in IFN modulation for gene 5 in the context of viral infection and will help to develop novel antiviral strategies.
Insights
A novel recombinant mouse-adapted MERS-CoV (rMERS-MA) was developed to study Middle East respiratory syndrome coronavirus pathogenesis. A MERS-CoV lacking gene 5 expression (rMERS-MA-Δ5) proved more virulent, suggesting gene 5 modulates pathogenesis.
Area of Science:
- Virology
- Immunology
- Pathogenesis
Background:
- Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe pneumonia with high mortality.
- Understanding MERS-CoV pathogenesis is limited due to scarce patient data and challenges in animal model development.
- Human dipeptidyl peptidase 4 knock-in (hDPP4-KI) mice offer a model for MERS-CoV infection.
Purpose of the Study:
- To engineer a reverse-genetics system for a mouse-adapted MERS-CoV (rMERS-MA) to study pathogenesis.
- To investigate the role of MERS-CoV gene 5 in viral virulence and host immune response.
- To identify potential targets for novel antiviral strategies.
Main Methods:
- Engineered a mouse-adapted MERS-CoV infectious cDNA (rMERS-MA) from MERS-MA-6-1-2.
- Created viruses with full-length gene 5 (rMERS-MA-5FL) or complete gene 5 deletion (rMERS-MA-Δ5).
- Infected hDPP4-KI mice with engineered viruses and analyzed viral load, pathology, and host immune responses (interferon, cytokines).
Main Results:
- The engineered rMERS-MA was virulent in hDPP4-KI mice, mimicking MERS-CoV clinical signs.
- MERS-CoV adaptation led to gene 5 mutations/deletions, while gene 5 is stable in human and camel field isolates.
- rMERS-MA-Δ5 infection resulted in higher mortality than the parental virus, with delayed and dysregulated interferon and cytokine expression in lungs.
Conclusions:
- The rMERS-MA reverse-genetics system is valuable for studying MERS-CoV pathogenesis.
- MERS-CoV gene 5 plays a role in modulating pathogenesis and host immune responses.
- The residual gene 5 sequence in the parental virus may ameliorate MERS-CoV pathogenesis, offering insights for antiviral development.


